This Round $2(min) - 6M
Heading to mass production, secure FDA approval & sales.​​
Innovative imaging to detect skin and lesion deformities for cosmetics and skin cancer. Patented.
​Problem: Currently, Skin cancer detection that relies on Color change, which happens at a late stage, leads to a high mortality rate.
Solution: An innovative handheld scanner to detect deformities under the skin at an EARLY stage.
The need: About 1.9 billion people with skin deformities.
​The Market: Dermatologists, General practitioners (GPs), Beauticians, and Home Users worldwide.
Revenues: $200 for a unit, AI use/SaaS, Virtual Meeting, Pay Per Use, and Reimbursement.
​
Shark Tank - First Prize Winner
Optional
Non-Diluted funds
Leveraging the investment
Schedule a Zoom meeting to hear more
​
Hey, I am Doctor Ofir, a Nuclear and Electrical Engineer, with a PhD in Electro-Optics, and the CEO of Patternox. Motivated by my mother's battle with skin cancer, I invented the PatScope scanner, Patent Granted! Powered by AI, PatScope detects lesion deformities, a warning sign of skin abnormalities and skin cancer.
​
-
Skin cancer detection that relies on color change, which happens at a LATE stage, leads to a high mortality rate.
-
Our solution, PatScope, detects deformities under the skin at an EARLY stage, before they become visible.
-
PatScope is a first award winner, two times.
-
You see, there are about 1.9 billion people with skin deformities. PatScope is designed for use at the point of care by dermatologists, GPs, beauticians, and for home monitoring.
-
It’s already been tested with over 500 lesions at the SKINCENTER in Florida, achieving an impressive first-of-its-kind imaging of skin deformities.
-
Revenue models are Device sales, AI diagnostics, telemedicine, pay-per-use, and reimbursements